Outputs (10)

AB0727 Hip osteoporosis and vertebral fractures are associated with younger age at diagnosis of spondyloarthritis: results from the comospa study (2025)
Presentation / Conference Contribution
Derakhshan, M., Goodson, N., Packham, J., Sengupta, R., Marzo-Ortega, H., Molto, A., & Siebert, S. AB0727 Hip osteoporosis and vertebral fractures are associated with younger age at diagnosis of spondyloarthritis: results from the comospa study. Presented at EULAR 2017, Madrid, Spain

Background
Spondyloarthritis (SpA) is associated with adverse bone health outcomes. It is not known whether age at disease diagnosis is associated with osteoporosis and fracture in later life.... Read More about AB0727 Hip osteoporosis and vertebral fractures are associated with younger age at diagnosis of spondyloarthritis: results from the comospa study.

Psoriatic Arthritis Priority Setting Partnership: patient- and clinician-informed considerations for future UK health service delivery. (2024)
Journal Article
James, L., Hailey, L., Bundy, C., Burstow, H., Chandler, D., Cowper, R., Helliwell, P., Joannes, L., Kelly, A., Kennedy, B., Kinsella, S., McAteer, H., Mukherjee, S., Packham, J., Wise, E., Young, H., Dures, E., & Coates, L. C. (in press). Psoriatic Arthritis Priority Setting Partnership: patient- and clinician-informed considerations for future UK health service delivery. Rheumatology, 1-6. https://doi.org/10.1093/rheumatology/keae680

Little is known about the ideal service delivery model and shortcomings in patient experiences in the NHS for patients with Psoriatic Arthritis (PsA). To identify unmet needs perceived within the current health service delivery model for PsA from the... Read More about Psoriatic Arthritis Priority Setting Partnership: patient- and clinician-informed considerations for future UK health service delivery..

Incidence of psoriatic arthritis in a UK primary care psoriasis population. (2024)
Journal Article
Rudge, A., Brown, S. T., Ransom, M., Helliwell, P. S., Packham, J., Tillett, W., Smith, T., & McHugh, N. J. (2024). Incidence of psoriatic arthritis in a UK primary care psoriasis population. The Journal of Rheumatology, 51(9), Article jrheum.2024-0556. https://doi.org/10.3899/jrheum.2024-0556

To determine the annual incidence of psoriatic arthritis in a UK primary care population with preexisting psoriasis followed prospectively over two years after excluding baseline prevalence of existing disease. TUDOR (Total bUrDen of psORiasis) was a... Read More about Incidence of psoriatic arthritis in a UK primary care psoriasis population..

Enhanced surveillance for the detection of psoriatic arthritis in a UK primary care psoriasis population: results from the TUDOR trial (2024)
Journal Article
McHugh, N., Tillett, W., Helliwell, P., Packham, J., Collier, H., Davies, C., Ransom, M., Coates, L., & Brown, S. T. (in press). Enhanced surveillance for the detection of psoriatic arthritis in a UK primary care psoriasis population: results from the TUDOR trial. Rheumatology, Article keae374. https://doi.org/10.1093/rheumatology/keae374

Background Our objective was to determine whether early detection of undiagnosed psoriatic arthritis (PsA) in a primary care psoriasis population improves outcome in physical function at 24 months post-registration. Methods A multicentre, prospective... Read More about Enhanced surveillance for the detection of psoriatic arthritis in a UK primary care psoriasis population: results from the TUDOR trial.

E041 Feasibility and acceptability of electronic patient reported outcome measures in the routine care of people with inflammatory arthritis: Haywood Arthritis Portal study (2024)
Presentation / Conference Contribution
Cox, N., Kettle, C., Wang, H., Dutta, S., Packham, J., Galloway, J., Hill, J., Muller, S., Hider, S., Paskins, Z., Bullock, L., & Scott, I. C. (2024, April). E041 Feasibility and acceptability of electronic patient reported outcome measures in the routine care of people with inflammatory arthritis: Haywood Arthritis Portal study. Poster presented at British Society for Rheumatology Annual Conference 2024

Background/Aims Electronic patient-reported outcome measures (ePROMs) assessing disease activity, function, pain, and quality of life can facilitate innovative inflammatory arthritis (IA) care, such as automating patient-initiated follow-up. This mix... Read More about E041 Feasibility and acceptability of electronic patient reported outcome measures in the routine care of people with inflammatory arthritis: Haywood Arthritis Portal study.

Barriers and facilitators in diagnosing axial spondyloarthritis: a qualitative study (2024)
Journal Article
Hay, C. A., Packham, J., Prior, J. A., Mallen, C. D., & Ryan, S. (2024). Barriers and facilitators in diagnosing axial spondyloarthritis: a qualitative study. Rheumatology International, 44, 863–884. https://doi.org/10.1007/s00296-024-05554-z

Diagnosis of axial spondyloarthritis (axSpA) is frequently delayed for years after symptom onset. However, little is known about patient and healthcare professional (HCP) perspectives on barriers and facilitators in axSpA diagnosis. This study explor... Read More about Barriers and facilitators in diagnosing axial spondyloarthritis: a qualitative study.

FRI0456 Age at spondyloarthritis diagnosis and risk of cardiovascular comorbidity: results from the comospa study (2017)
Presentation / Conference
Derakhshan, M., Goodson, N., Packham, J., Sengupta, R., Marzo-Ortega, H., Molto, A., & Siebert, S. (2017, June). FRI0456 Age at spondyloarthritis diagnosis and risk of cardiovascular comorbidity: results from the comospa study. Poster presented at EULAR 2017, Madrid, Spain

Background
Spondyloarthritis (SpA) and chronic inflammatory diseases are associated with a number of cardiovascular comorbidities. It is unknown whether age at SpA diagnosis is associated with cardiovascular outco... Read More about FRI0456 Age at spondyloarthritis diagnosis and risk of cardiovascular comorbidity: results from the comospa study.

SAT0011 Replication of A Distinct Psoriatic Arthritis Risk Variant at IL23R (2016)
Presentation / Conference Contribution
Budu-Aggrey, A., Bowes, J., Lohr, S., Uebe, S., Zervou, M., Helliwell, P., Ryan, A., Kane, D., Korendowych, E., Giardina, E., Packham, J., McManus, R., FitzGerald, O., McHugh, N., Behrens, F., Burkhardt, H., Huffmeier, U., Ho, P., Martin, J., Castañeda, S., …Barton, A. (2016, June). SAT0011 Replication of A Distinct Psoriatic Arthritis Risk Variant at IL23R. Poster presented at EULAR 2016, London, England

Background
Psoriatic arthritis (PsA) is an inflammatory arthritis that is associated with psoriasis. Although the majority of PsA genetic risk loci identified also confer risk for psoriasis, we have recently repor... Read More about SAT0011 Replication of A Distinct Psoriatic Arthritis Risk Variant at IL23R.

THU0003 Fine-mapping of autoimmune susceptibility LOCI using immunochip identifies novel susceptibility LOCI for psoriatic arthritis (2012)
Presentation / Conference
Bowes, J., Ho, P., Korendowych, E., McHugh, N., Packham, J., Bruce, I., & Barton, A. (2012, June). THU0003 Fine-mapping of autoimmune susceptibility LOCI using immunochip identifies novel susceptibility LOCI for psoriatic arthritis. Poster presented at EULAR 2012, Berlin, Germany

Background
Psoriatic arthritis (PsA) is a chronic inflammatory joint disease that typically accompanies psoriasis vulagris (PsV). Both conditions are considered to be complex diseases with both genetic and environ... Read More about THU0003 Fine-mapping of autoimmune susceptibility LOCI using immunochip identifies novel susceptibility LOCI for psoriatic arthritis.

SAT0007 Fine-mapping of the 5Q31 psoriatic arthritis susceptibility LOCI in a british population (2012)
Presentation / Conference Contribution
Bluett, J., Bowes, J., Ho, P., Korendowych, E., McHugh, N., Packham, J., Bruce, I., & Barton, A. (2012, June). SAT0007 Fine-mapping of the 5Q31 psoriatic arthritis susceptibility LOCI in a british population. Poster presented at EULAR 2012, Berlin, Germany

Background
Psoriatic Arthritis (PsA) is a chronic inflammatory arthritis associated with psoriasis which manifests as a heterogeneous disease with a wide spectrum of disease severity. PsA is a complex disease wher... Read More about SAT0007 Fine-mapping of the 5Q31 psoriatic arthritis susceptibility LOCI in a british population.